Acytronix develops a portable microstructured electrochemical device (PMED) that rapidly purifies extracellular vesicles (EVs) from raw physiological fluids in under 10 minutes, achieving 98% purity. This technology enables biopharmaceutical companies and research institutions to efficiently isolate nanometric biological entities, facilitating advancements in personalized medicine and nanoparticle research.
Funding
$10K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for purifying extracellular vesicles (EVs) from biological fluids are often time-consuming and require specialized laboratory equipment. This limits the ability to rapidly isolate and analyze EVs for research and diagnostic purposes, hindering advancements in personalized medicine and nanoparticle research.
Solution
Acytronix has developed a portable microstructured electrochemical device (PMED) that enables rapid purification of EVs from raw physiological fluids. The PMED system allows for separation of bio-entities from raw samples in under 10 minutes, achieving a purity level where 98% of scattered light is attributable to EVs. This technology facilitates efficient isolation of nanometric biological entities, making it easier to study and utilize EVs in various applications. The system includes the PMED device, releasing unit, controlled syringe, and disposable separation cartridges.
Target Audience
The primary target audience includes biopharmaceutical companies and research institutions involved in personalized medicine, nanoparticle research, and EV-based diagnostics and therapeutics.
Features
- Rapid EV purification from raw physiological fluids in under 10 minutes
- Portable device for on-site sample processing
- High purity levels, with 98% of scattered light attributable to EVs
- Electrochemical separation method for efficient bio-entity isolation
- PMED Kit including device, releasing unit, controlled syringe, and disposable cartridges
- Custom separation services for nanometric biological entities (30-1000 nm)
- Custom EV separation services, including sub-population sorting (e.g., Anti-CD9, Anti-CD63, Anti-CD72)